To determine whether CCLE mitigates acute IBD through its anti-inflammatory effects, we measured the serum levels of pro-inflammatory cytokines, including IL-6, TNF-α, and IL-1β, as well as colon myeloperoxidase (MPO) using ELISA. This evidence concerns the gene IL6 and inflammatory bowel disease.